The Icos Alumni: Where Are They Now?

Abby Kliphardt, production chemist, Bio-Rad Laboratories

Joshua Klocke, associate scientist IV, MDS Pharma Services

Byron Kneller, senior staff scientist, CMC Icos

Gabrielle Kolakowski, associate scientist, Array Biopharma

Sandy Kopponol, city council member, city of Lake Forest Park

Yvonne Lai, professor of biology, Indiana University

Keith Laycock, network analyst, City of Redmond

Sam Lee, president, CoCrystal Discovery

Dina Leviten, scientist, Ikaria

Michael Libby, assistant director of quality control, Irix Pharmaceuticals

Marykay Ligocki, research scientist

Mong-Wu Lin, quality control associate, Dharma Therapeutics

Brian Lipsky, senior associate research scientist, Amgen

Mila Lobanova, senior director of finance, ZymoGenetics

Christine Loh, associate director, Sirtris Pharmaceuticals

Kate Loughney, medical and scientific writing

Andrew Lover, graduate student researcher, National University of Singapore

Mark Lupher, senior vice president of drug discovery, Promedior

Mack Mabry, senior director, Trubion Pharmaceuticals

Linda MacKeen, director of medical writing, Seattle Genetics

Patricia Magnafichi, procurement manager, Genentech

Benjamin Maier, quality assurance senior specialist, CMC Icos

Linda Mangone, director of organization development and learning, Regence Blue Cross/BlueShield

Timothy Martins, co-director Quellos High Throughput Screening Core, Institute for Stem Cell and Regenerative Medicine, University of Washington

Mari Maurer, director of clinical operations, BioMarin Pharmaceutical [Added 12/30/09]

Kim Nordstrom McCaw, biotechnology professional

David McElligott, vice president of research and development, Mirina

William McFee, scientist, Seattle Genetics

David Meyer, senior research associate, Seattle Genetics

Greg Miller, scientist, Bayer Healthcare

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.